Long-term follow-up for cardiac arrest survivors and their caregivers
Extended Follow-up Substudy of the Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation -STEPCARE Trial
This study is testing how well survivors of out-of-hospital cardiac arrest recover over time and how it affects their caregivers, with a focus on their thinking skills and overall well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 34 sites (Brisbane and 33 other locations) |
| Trial ID | NCT06207942 on ClinicalTrials.gov |
What this trial studies
This substudy aims to gather detailed information on the long-term outcomes of survivors of out-of-hospital cardiac arrest, focusing on cognitive function and caregiver burden at 6 and 12 months post-resuscitation. Participants will be part of the larger STEPCARE trial, which investigates different management strategies for sedation, temperature, and blood pressure after cardiac arrest. Approximately 600 survivors and their nominated caregivers will be enrolled, with follow-ups conducted to assess recovery and the impact on caregivers. The study will utilize various interventions, including temperature control and sedation management.
Who should consider this trial
Good fit: Ideal candidates include survivors of out-of-hospital cardiac arrest who have provided consent and are participating in the STEPCARE trial.
Not a fit: Patients who do not survive the initial cardiac arrest or those with conditions like pregnancy or intracranial hemorrhage may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery strategies for cardiac arrest survivors and better support for their caregivers.
How similar studies have performed: Other studies have shown promise in improving outcomes for cardiac arrest survivors through targeted management strategies, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
All OHCA participants randomized in the STEPCARE trial at the extended follow-up participating sites, who survive and provide consent, with no further inclusion or exclusion criteria. The inclusion and exclusion criteria for the STEPCARE trial are: * Inclusion criteria: out-of-hospital cardiac arrest of non-traumatic origin, minimum of 20 minutes without chest compressions (defined as stable return of spontaneous circulation. ROSC), unconsciousness (defined as not being able to obey verbal commands equal to a FOUR-score motor response of \<4, or being intubated and sedated because of agitation after sustained ROSC, eligible for intensive care without restrictions or limitation, inclusion within 4 hours (240 minutes) of ROSC (or 220 minutes of stable ROSC). * Exclusion criteria: on ECMO prior to randomization, pregnancy, suspected or confirmed intracranial hemorrhage, previously randomized in the STEPCARE trial. For caregivers, the eligibility will be that they live with, or have weekly or more frequent contact (in person or over the telephone) with the post OHCA survivor. Only one nominated caregiver per post OHCA survivor will be able to be included in the study. This would typically be the caregiver that would identify as the primary caregiver of the post OHCA survivor if needed, but may also be another close family member.
Where this trial is running
Brisbane and 33 other locations
- Princess Alexandra Hospital — Brisbane, Australia (Recruiting)
- The Sutherland Hospital — Caringbah, Australia (Recruiting)
- The Prince Charles Hospital — Chermside, Australia (Recruiting)
- Nepean hospital — Kingswood, Australia (Recruiting)
- St George hospital — Kogarah, Australia (Recruiting)
- Liverpool hospital — Liverpool, Australia (Recruiting)
- Austin hospital — Melbourne, Australia (Recruiting)
- Royal North Shore Hospital — Sydney, Australia (Recruiting)
- Ziekenhuis Oost Limburg — Genk, Belgium (Recruiting)
- Ghent university hospital — Ghent, Belgium (Recruiting)
- Helsinki Helsingfors university central hospital — Helsinki, Finland (Recruiting)
- Jorvi hospital — Jorvi, Finland (Recruiting)
- Tampere university hospital — Tampere, Finland (Recruiting)
- Charite university hospital — Berlin, Germany (Recruiting)
- Universitäres Herzzentrum Lübeck Universitätsklinikum Schleswig-Holstein — Lübeck, Germany (Recruiting)
- Tubingen university hospital — Tübingen, Germany (Recruiting)
- Centre Hospitalier de Luxembourg — Luxembourg, Luxembourg (Recruiting)
- Auckland city hospital — Auckland, New Zealand (Recruiting)
- Middlemore hospital — Auckland, New Zealand (Recruiting)
- Christchurch hospital — Christchurch, New Zealand (Recruiting)
- Wellington hospital — Wellington, New Zealand (Recruiting)
- Sorlandet hospital — Arendal, Norway (Recruiting)
- Oslo university hospital Rikshospitalet — Oslo, Norway (Recruiting)
- Sahlgrenska university hospital — Gothenburg, Sweden (Recruiting)
- Hallands hospital — Hålland, Sweden (Recruiting)
- Helsingborg hospital — Helsingborg, Sweden (Recruiting)
- Skåne university hospital — Lund, Sweden (Recruiting)
- Skåne university hopsital — Malmö, Sweden (Recruiting)
- Bern university hospital — Bern, Switzerland (Recruiting)
- Kantonsspital St. Gallen — Sankt Gallen, Switzerland (Recruiting)
- The Essex Cardiothoracic Centre — Basildon, United Kingdom (Recruiting)
- Bristol Royal Infirmary — Bristol, United Kingdom (Recruiting)
- University hospital of Wales — Cardiff, United Kingdom (Recruiting)
- St Bartholomew's hospital — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Gisela Lilja, PhD
- Email: gisela.lilja@med.lu.se
- Phone: +4646176393
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.